
EXACT Therapeutics is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT®sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Biotechnology

EXACT Therapeutics

Per Walday

Caspar Foghsgaard

Danishad Appu

John M. Edminson

Morten Smedsrud Wigen

Hilary Mcelwaine-Johnn

Ragnar Bendiksen

Melina Mühlenpfordt

Amir Snapir

Svein Kvåle

Leadership Team

C-Suite

Medical and Clinical Team

��

Teams at EXACT Therapeutics

Leadership Team

C-Suite

Medical and Clinical Team

��������

Teams at EXACT Therapeutics

Leadership Team

C-Suite

Medical and Clinical Team

��